Gunze Limited, based in Osaka, Japan (TOKYO:3002), has disclosed that its subsidiary, Gunze Medical Limited, has partnered with HistoSonics, Inc., headquartered in Minneapolis, MN USA, to distribute a noninvasive platform and proprietary sonic beam therapy featuring histotripsy technology. The agreement is exclusive and marks a significant collaboration between the companies. Gunze Limited's President is Toshiyasu Saguchi, while Gunze Medical Limited's President is Shojiro Matsuda and HistoSonics, Inc.'s CEO is Mike Blue.